Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1999 1
2000 3
2001 4
2002 8
2003 4
2004 7
2005 7
2006 7
2007 4
2008 5
2009 5
2010 4
2011 6
2012 6
2013 14
2014 19
2015 8
2016 15
2017 11
2018 8
2019 11
2020 12
2021 23
2022 8
Text availability
Article attribute
Article type
Publication date

Search Results

169 results
Results by year
Filters applied: . Clear all
Page 1
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087.
Chen R, Zinzani PL, Lee HJ, Armand P, Johnson NA, Brice P, Radford J, Ribrag V, Molin D, Vassilakopoulos TP, Tomita A, von Tresckow B, Shipp MA, Lin J, Kim E, Nahar A, Balakumaran A, Moskowitz CH. Chen R, et al. Among authors: vassilakopoulos tp. Blood. 2019 Oct 3;134(14):1144-1153. doi: 10.1182/blood.2019000324. Epub 2019 Aug 13. Blood. 2019. PMID: 31409671 Free PMC article. Clinical Trial.
Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial.
Kalakonda N, Maerevoet M, Cavallo F, Follows G, Goy A, Vermaat JSP, Casasnovas O, Hamad N, Zijlstra JM, Bakhshi S, Bouabdallah R, Choquet S, Gurion R, Hill B, Jaeger U, Sancho JM, Schuster M, Thieblemont C, De la Cruz F, Egyed M, Mishra S, Offner F, Vassilakopoulos TP, Warzocha K, McCarthy D, Ma X, Corona K, Saint-Martin JR, Chang H, Landesman Y, Joshi A, Wang H, Shah J, Shacham S, Kauffman M, Van Den Neste E, Canales MA. Kalakonda N, et al. Among authors: vassilakopoulos tp. Lancet Haematol. 2020 Jul;7(7):e511-e522. doi: 10.1016/S2352-3026(20)30120-4. Lancet Haematol. 2020. PMID: 32589977 Free article. Clinical Trial.
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma.
Chen R, Zinzani PL, Fanale MA, Armand P, Johnson NA, Brice P, Radford J, Ribrag V, Molin D, Vassilakopoulos TP, Tomita A, von Tresckow B, Shipp MA, Zhang Y, Ricart AD, Balakumaran A, Moskowitz CH; KEYNOTE-087. Chen R, et al. Among authors: vassilakopoulos tp. J Clin Oncol. 2017 Jul 1;35(19):2125-2132. doi: 10.1200/JCO.2016.72.1316. Epub 2017 Apr 25. J Clin Oncol. 2017. PMID: 28441111 Free PMC article. Clinical Trial.
Real-life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B-cell lymphomas.
Dimou M, Papageorgiou SG, Stavroyianni N, Katodritou E, Tsirogianni M, Kalpadakis C, Banti A, Arapaki M, Iliakis T, Bouzani M, Verrou E, Spanoudakis E, Giannouli S, Marinakis T, Mandala E, Mparmparousi D, Sachanas S, Dalekou-Tsolakou M, Hatzimichael E, Vadikolia C, Violaki V, Poziopoulos C, Tsirkinidis P, Chatzileontiadou S, Vervessou E, Ximeri M, Sioni A, Konstantinidou P, Kyrtsonis MC, Siakantaris MP, Angelopoulou MK, Pappa V, Konstantopoulos K, Panayiotidis P, Vassilakopoulos TP. Dimou M, et al. Among authors: vassilakopoulos tp. Hematol Oncol. 2021 Aug;39(3):336-348. doi: 10.1002/hon.2842. Epub 2021 Mar 2. Hematol Oncol. 2021. PMID: 33583077
Hodgkin lymphoma: Introduction.
Engert A, Vassilakopoulos TP. Engert A, et al. Among authors: vassilakopoulos tp. Semin Hematol. 2016 Jul;53(3):137-8. doi: 10.1053/j.seminhematol.2016.05.001. Epub 2016 May 12. Semin Hematol. 2016. PMID: 27496303 No abstract available.
Nodal marginal zone lymphoma.
Angelopoulou MK, Kalpadakis C, Pangalis GA, Kyrtsonis MC, Vassilakopoulos TP. Angelopoulou MK, et al. Among authors: vassilakopoulos tp. Leuk Lymphoma. 2014 Jun;55(6):1240-50. doi: 10.3109/10428194.2013.840888. Epub 2013 Nov 12. Leuk Lymphoma. 2014. PMID: 24004184 Review.
Treatment of splenic marginal zone lymphoma.
Kalpadakis C, Pangalis GA, Angelopoulou MK, Vassilakopoulos TP. Kalpadakis C, et al. Among authors: vassilakopoulos tp. Best Pract Res Clin Haematol. 2017 Mar-Jun;30(1-2):139-148. doi: 10.1016/j.beha.2016.07.004. Epub 2016 Nov 4. Best Pract Res Clin Haematol. 2017. PMID: 28288709 Review.
Prognostic factors in Hodgkin lymphoma.
Bröckelmann PJ, Angelopoulou MK, Vassilakopoulos TP. Bröckelmann PJ, et al. Among authors: vassilakopoulos tp. Semin Hematol. 2016 Jul;53(3):155-64. doi: 10.1053/j.seminhematol.2016.05.003. Epub 2016 May 12. Semin Hematol. 2016. PMID: 27496306 Review.
Treatment of advanced-stage Hodgkin lymphoma.
Vassilakopoulos TP, Johnson PW. Vassilakopoulos TP, et al. Semin Hematol. 2016 Jul;53(3):171-9. doi: 10.1053/j.seminhematol.2016.05.006. Epub 2016 May 12. Semin Hematol. 2016. PMID: 27496308 Review.
Clinical aspects of malt lymphomas.
Kalpadakis C, Pangalis GA, Vassilakopoulos TP, Kyriakaki S, Yiakoumis X, Sachanas S, Moschogiannis M, Tsirkinidis P, Korkolopoulou P, Papadaki HA, Angelopoulou MK. Kalpadakis C, et al. Among authors: vassilakopoulos tp. Curr Hematol Malig Rep. 2014 Sep;9(3):262-72. doi: 10.1007/s11899-014-0218-1. Curr Hematol Malig Rep. 2014. PMID: 25240474 Review.
169 results